Elanco Animal Health Inc
ELAN
Get informed when a big investor buys or sells
+ FollowMarket Cap$11.06B
Close$
$-0.20
100.9% downside
Current Fair Value
100.9% downsideOvervalued by 100.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $11.06 Billion |
|---|---|
| Enterprise Value | $14.45 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.47 |
| Beta | 1.68 |
| Outstanding Shares | 499,500,000 |
Return
| Return on Equity | -3.02% |
|---|---|
| Return on Assets | -1.47% |
| Return on Invested Capital | 3.50% |
Valuation & Multiples
| P/E Ratio | -54 |
|---|---|
| PEG | -13.81 |
| Price to Sales | 2.21 |
| Price to Book Ratio | 1.7 |
| Enterprise Value to Revenue | 2.88 |
| Enterprise Value to EBIT | 35.23 |
| Enterprise Value to Net Income | -73 |
| Total Debt to Enterprise | 0.27 |
| Debt to Equity | 0.59 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 6, 2026
EPS Estimate
$0.28
Average shareholder expectationRevenue Estimate
$1.31 B
Average shareholder expectationNext Earnings Call
Expected Date
November 4, 2026
EPS Estimate
$0.20
Average shareholder expectationRevenue Estimate
$1.21 B
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.5731▼ 20.20% |
|---|---|
| Total Calls | 305,000▼ 50.72% |
| Total Puts | 174,800▼ 63.56% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 114.22%▲ 4.61% |
|---|---|
| Total Invested | $14.04B▲ 7.57% |
| Investors Holding | 534▲ 2.00% |
ESG Score
No data